New 52 Week Low Today

Evoke Pharma Inc EVOK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:50 PM EDT
0.45quote price arrow down-0.03 (-6.25%)
Volume
6,706
52 week range
0.41 - 2.40
Loading...
  • Open0.453
  • Day High0.478
  • Day Low0.4104
  • Prev Close0.48
  • 52 Week High2.40
  • 52 Week High Date05/09/23
  • 52 Week Low0.41
  • 52 Week Low Date05/02/24

Key Stats

  • Market Cap3.815M
  • Shares Out8.48M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-57.16

KEY STATS

  • Open0.453
  • Day High0.478
  • Day Low0.4104
  • Prev Close0.48
  • 52 Week High2.40
  • 52 Week High Date05/09/23
  • 52 Week Low0.41
  • 52 Week Low Date05/02/24
  • Market Cap3.815M
  • Shares Out8.48M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.33
  • YTD % Change-57.16

RATIOS/PROFITABILITY

  • EPS (TTM)-2.33
  • P/E (TTM)-0.19
  • Fwd P/E (NTM)-1.25
  • EBITDA (TTM)-7.431M
  • ROE (TTM)-1,035.45%
  • Revenue (TTM)5.181M
  • Gross Margin (TTM)96.10%
  • Net Margin (TTM)-150.41%
  • Debt To Equity (MRQ)-193.83%

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Evoke Pharma Inc

 

Profile

MORE
Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development and commercialization of drugs to treat gastrointestinal (GI) disorders and diseases. The Company operates through the development and commercialization of pharmaceutical products. It is developing its product, Gimoti (metoclopramide) nasal spray, the first and only nasally administered product indicated for the relief of symptoms in adults with acute and recurrent...
Cam Garner
Independent Chairman of the Board
Matthew D'Onofrio
President, Chief Executive Officer, Treasurer, Secretary, Director
Address
420 Stevens Avenue, Suite 370
Solana Beach, CA
92075
United States

Top Peers

SYMBOLLASTCHG%CHG
DMKPQ
DMK Pharmaceuticals Corp
0.0333UNCHUNCH
TRVN
Trevena Inc
0.4097+0.0259+6.7483%
ACUR
Acura Pharmaceuticals Inc
0.003-0.007-70.00%
INFIQ
Infinity Pharmaceuticals Inc
0.00UNCHUNCH
NAVB
Navidea Biopharmaceuticals Inc
0.035UNCHUNCH